{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T19:52:48Z","timestamp":1694634768161},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>A 43-year-old man with locally advanced squamous cell carcinoma of the base of tongue was treated with induction chemotherapy followed by intensity-modulated radiation therapy (IMRT). Within 20 days post-treatment, the patient developed clinical symptoms highly suggestive of hyperthyroidism. Two and one half months after completion of therapy, the patient developed severe thyrotoxicosis, which, in retrospect, appears to have met the criteria for thyroid storm. This case history illustrates a previously unreported, life-threatening complication of external-beam radiation that should be considered in patients receiving IMRT therapy involving the thyroid. Diagnosis of the patient's hyperthyroidism and probable thyroid storm was difficult to recognize because of the significant overlap between the signs and symptoms of severe thyrotoxicosis and the expected toxicities of his cancer therapy.<\/jats:p>","DOI":"10.1634\/theoncologist.2008-0156","type":"journal-article","created":{"date-parts":[[2009,3,14]],"date-time":"2009-03-14T00:39:42Z","timestamp":1236991182000},"page":"233-239","source":"Crossref","is-referenced-by-count":5,"title":["Thyroid Storm After Intensity-Modulated Radiation Therapy: A Case Report and Discussion"],"prefix":"10.1093","volume":"14","author":[{"given":"Roberto","family":"Diaz","sequence":"first","affiliation":[{"name":"a Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc D.","family":"Blakey","sequence":"additional","affiliation":[{"name":"a Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick B.","family":"Murphy","sequence":"additional","affiliation":[{"name":"b Tennessee Oncology, Franklin, Tennessee, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Keith","family":"Cryar","sequence":"additional","affiliation":[{"name":"c Maury Regional Medical Center, Columbia, Tennessee, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony J.","family":"Cmelak","sequence":"additional","affiliation":[{"name":"a Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,3,13]]},"reference":[{"key":"2021122207503822200_R1","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa070956","article-title":"Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer","volume":"357","author":"Posner","year":"2007","journal-title":"N Engl J Med"},{"key":"2021122207503822200_R2","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa071028","article-title":"Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer","volume":"357","author":"Vermorken","year":"2007","journal-title":"N Engl J Med"},{"key":"2021122207503822200_R3","doi-asserted-by":"crossref","first-page":"S464","DOI":"10.1016\/j.ijrobp.2007.07.1649","article-title":"Intensity-modulated radiation therapy (IMRT) with concurrent taxane-based chemotherapy for locally-advanced head and neck cancer (LAHNC): Toxicities and efficacy","volume":"69","author":"Diaz","year":"2007","journal-title":"Int J Radiat Oncol"},{"key":"2021122207503822200_R4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0002-9343(83)91217-2","article-title":"Radioiodine-induced thyroid storm. Case report and literature review","volume":"75","author":"McDermott","year":"1983","journal-title":"Am J Med"},{"key":"2021122207503822200_R5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ecl.2006.09.008","article-title":"Thyrotoxicosis and thyroid storm","volume":"35","author":"Nayak","year":"2006","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2021122207503822200_R6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jemermed.2004.08.020","article-title":"Thyroid disease in the emergency department: A clinical and laboratory review","volume":"28","author":"Pimentel","year":"2005","journal-title":"J Emerg Med"},{"key":"2021122207503822200_R7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0889-8529(18)30165-8","article-title":"Life-threatening thyrotoxicosis. Thyroid storm","volume":"22","author":"Burch","year":"1993","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2021122207503822200_R8","doi-asserted-by":"crossref","first-page":"694","DOI":"10.7326\/0003-4819-93-5-694","article-title":"Free thyroxine concentrations in thyroid storm","volume":"93","author":"Brooks","year":"1980","journal-title":"Ann Intern Med"},{"key":"2021122207503822200_R9","first-page":"491","article-title":"Case reports. Hyperthyroidism in the presence of panhypopituitarism. Thyroid crisis and hypothyroidism following radioiodine treatment","volume":"120","author":"Krishnamurthy","year":"1974","journal-title":"West J Med"},{"key":"2021122207503822200_R10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1651-2227.1999.tb14399.x","article-title":"Thyroid consequences of the Chernobyl nuclear accident","volume":"88","author":"Pacini","year":"1999","journal-title":"Acta Paediatr Suppl"},{"key":"2021122207503822200_R11","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1089\/thy.1999.9.781","article-title":"Post-Chernobyl increased prevalence of humoral thyroid autoimmunity in children and adolescents from a moderately iodine-deficient area in Russia","volume":"9","author":"Vermiglio","year":"1999","journal-title":"Thyroid"},{"key":"2021122207503822200_R12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4065\/83.4.489","article-title":"Head and neck cancer: Changing epidemiology, diagnosis, and treatment","volume":"83","author":"Marur","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"2021122207503822200_R13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM199108293250902","article-title":"Thyroid diseases after treatment of Hodgkin's disease","volume":"325","author":"Hancock","year":"1991","journal-title":"N Engl J Med"},{"key":"2021122207503822200_R14","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/0360-3016(95)00019-U","article-title":"Thyroid abnormalities after therapeutic external radiation","volume":"31","author":"Hancock","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122207503822200_R15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ctrv.2003.12.003","article-title":"Radiotherapy-induced thyroid disorders","volume":"30","author":"Jereczek-Fossa","year":"2004","journal-title":"Cancer Treat Rev"},{"key":"2021122207503822200_R16","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0360-3016(96)00480-4","article-title":"Acute radiation thyroiditis","volume":"36","author":"Nishiyama","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122207503822200_R17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0360-3016(95)02079-9","article-title":"A prospective analysis of subacute thyroid dysfunction after neck irradiation","volume":"34","author":"Nishiyama","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122207503822200_R18","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/1097-0142(19840215)53:4<878::AID-CNCR2820530411>3.0.CO;2-J","article-title":"Thyroid dysfunction after radiotherapy in children with Hodgkin's disease","volume":"53","author":"Constine","year":"1984","journal-title":"Cancer"},{"key":"2021122207503822200_R19","first-page":"146","article-title":"[Hypothyroidism after radiotherapy to the neck]","volume":"64","author":"Yoden","year":"2004","journal-title":"Nippon Igaku Hoshasen Gakkai Zasshi"},{"key":"2021122207503822200_R20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0167-8140(00)00276-0","article-title":"Hypothyroidism after radiotherapy for laryngeal cancer","volume":"57","author":"Kumpulainen","year":"2000","journal-title":"Radiother Oncol"},{"key":"2021122207503822200_R21","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2008.26.15_suppl.6048","article-title":"Hypothyroidism as a consequence of intensity-modulated radiation therapy (IMRT) with concurrent taxane-based chemotherapy for locally-advanced head and neck cancer (LAHNC)","volume-title":"Presented at the 2008 American Society of Clinical Oncology Annual Meeting","author":"Diaz"},{"key":"2021122207503822200_R22","first-page":"425","article-title":"Intensity-modulated radiotherapy for head and neck cancer","volume":"5","author":"Caglar","year":"2007","journal-title":"Clin Adv Hematol Oncol"},{"key":"2021122207503822200_R23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/hed.20332","article-title":"Intensity-modulated radiation therapy in head and neck cancers: An update","volume":"29","author":"Lee","year":"2007","journal-title":"Head Neck"},{"key":"2021122207503822200_R24","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1200\/JCO.2005.04.7225","article-title":"Intensity-modulated radiotherapy in the standard management of head and neck cancer: Promises and pitfalls","volume":"24","author":"Mendenhall","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2008-0156","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2008-0156","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/14\/3\/233\/41841488\/oncolo_14_3_233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/14\/3\/233\/41841488\/oncolo_14_3_233.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T09:45:33Z","timestamp":1640166333000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/14\/3\/233\/6397673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,1]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,3,13]]},"published-print":{"date-parts":[[2009,3,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2008-0156","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2009,3,1]]},"published":{"date-parts":[[2009,3,1]]}}}